Fresh tumor biopsies in world-first technique for cancer treatments

August 24, 2020

An innovative technique to improve cancer treatments using tumour biopsies less than 30 minutes after they're taken has been developed at The University of Queensland.

The 'Drug uptake in ex Vivo tumours' technique was developed after researchers found fresh patient tumour biopsies responded differently to treatments than the tissue cultures traditionally used.

Its inventor, UQ Diamantina Institute's Dr Fiona Simpson, said it could be used to show how long antibodies stayed active in patients, or when antibodies were taken into the tumour where they're destroyed.

"The technique will significantly help pharmaceutical and technology companies design future cancer drugs," Dr Simpson said.

"Until now, scientists have only looked at how cancer drugs interact with tissue culture, not fresh tumours.

"Applying medications to tissue culture doesn't always work because the immune system responds differently in a body.

"I thought it was pretty obvious that we should test cancer drugs on actual tumours, but people kept telling my research team that it wouldn't work!"

The technique includes a step-by-step process to help drug companies and researchers better understand how drugs interact with patients, and respond to targeted treatments.

"We've created a comprehensive process, including detailed videos on tumour extraction and drug-testing processes, for researchers around the world to use," she said.

"The technique is useful for all types of cancers, and we're very excited about its possibilities."
-end-
The research was published in Cell Press' STAR Protocols. DOI: 10.1016/j.xpro.2020.100087.

University of Queensland

Related Antibodies Articles from Brightsurf:

Scientist develops new way to test for COVID-19 antibodies
New research details how a cell-free test rapidly detects COVID-19 neutralizing antibodies and could aid in vaccine testing and drug discovery efforts.

Mussels connect antibodies to treat cancer
POSTECH research team develops innovative local anticancer immunotherapy technology using mussel protein.

For an effective COVID vaccine, look beyond antibodies to T-cells
Most vaccine developers are aiming solely for a robust antibody response against the SARS-CoV-2 virus, despite evidence that antibodies are not the body's primary protective response to infection by coronaviruses, says Marc Hellerstein of UC Berkeley.

Children can have COVID-19 antibodies and virus in their system simultaneously
With many questions remaining around how children spread COVID-19, Children's National Hospital researchers set out to improve the understanding of how long it takes pediatric patients with the virus to clear it from their systems, and at what point they start to make antibodies that work against the coronavirus.

The behavior of therapeutic antibodies in immunotherapy
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells.

Re-engineering antibodies for COVID-19
Catholic University of America researcher uses 'in silico' analysis to fast-track passive immunity

Seroprevalence of antibodies to SARS-CoV-2 in 10 US sites
This study estimates how common SARS-CoV-2 antibodies are in convenience samples from 10 geographic sites in the United States.

Neutralizing antibodies in the battle against COVID-19
An important line of defense against SARS-CoV-2 is the formation of neutralizing antibodies.

Three new studies identify neutralizing antibodies against SARS-CoV-2
A trio of papers describes several newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV infection.

More effective human antibodies possible with chicken cells
Antibodies for potential use as medicines can be made rapidly in chicken cells grown in laboratories.

Read More: Antibodies News and Antibodies Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.